Influenza — Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in Adults
Citation(s)
A Phase III, Randomized, Double-Blinded, Placebo-Controlled, Multi-Center Study to Evaluate the Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in Adults Greater Than or Equal to 18 to Less Than 65 Years of Age